Entelos

About:

Entelos is a provider of predictive biosimulation for drug discovery and development.

Website: http://www.entelos.com

Twitter/X: entelos

Top Investors: Earlybird Venture Capital, Sofinnova Investments, CRV, Clearlake Capital Group, Abingworth

Description:

Entelos is the leading provider of predictive biosimulation for drug discovery and development. We provide advanced biosimulation capabilities that make discovery more efficient and increase clinical success. For over 15 years, we have enabled R&D organizations to predict better paths to success by simulating systems biology. Our solutions include mechanism-based, mathematical models; virtual patients and populations; biosimulation software; and biosimulation expertise.

Total Funding Amount:

$39.6M

Headquarters Location:

San Mateo, California, United States

Founded Date:

1996-01-01

Contact Email:

support(AT)entelos.com

Founders:

Alex Bangs, Samuel Holtzman

Number of Employees:

11-50

Last Funding Date:

2013-06-21

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai